News

CytRx has received letter from the FDA regarding the arimoclomol phase IIb clinical trial. Under its guidelines, the FDA will have 30 days following CytRx’s planned protocol submission

eBioscience Corporation, a provider of cell analysis reagents, has acquired NatuTec GmbH, a distributor of biological research reagents located in Frankfurt am Main, Germany. The NatuTec acquisition is

Neoprobe and Laureate Pharma (Laureate) have entered into a Biopharmaceutical Development and Manufacturing Agreement. Under the agreement, Laureate will assist in the development and production of Neoprobe’s murine

The US Patent and Trademark Office (USPTO) publishes Stemedica Cell Technologies’ (Stemedica) patent application for the treatment of Diabetic Retinopathy. Reportedly, the application is supported by extensive data

OctoPlus has won an expansion of a drug delivery technology evaluation contract with an existing client, a global pharmaceutical company. In 2008 and 2009 OctoPlus performed preliminary feasibility

GeoPharma has reached agreement with Consolidated Pharmaceutical Group (CPG) and have entered into a Settlement and Mutual Release Agreement and other documents on September 4, 2009, settling all

Cell Biosciences and Alpha Innotech have entered into an agreement, by which Alpha Innotech will be acquired by Cell Biosciences for $1.50 per share, or approximately $17.9m in

Vaxart has been awarded a $2.8m phase II Small Business Innovation Research grant from the National Institute of Allergy and Infectious Disease (NIH) to support development of its

GeneGo has licensed MetaCore, its data mining and analysis platform, to Proteostasis Therapeutics (Proteostasis). Julie Bryant, VP of business development at GeneGo, said: We are very pleased to